Lahoti S, Fukami N
MD Anderson Cancer Center, 1515 Holcombe Boulevard, Box 78, Houston, TX 77030, USA.
Curr Gastroenterol Rep. 1999 Oct;1(5):424-30. doi: 10.1007/s11894-999-0025-3.
The small bowel is a rare but important source of blood loss from the gastrointestinal (GI) tract. In approximately 5% of all patients with GI bleeding, no cause for the bleeding is evident even after an extensive workup. This bleeding is often termed "gastrointestinal bleeding of obscure origin" or "obscure gastrointestinal bleed" (OGIB). Recent advancements in enteroscopy have contributed to a better understanding of the small bowel as a source of bleeding. On average, 27% of patients with OGIB have been shown to have lesions in the small bowel, with common findings including arteriovenous malformations (AVMs) and small bowel tumors. The trend in primary diagnostic workup for obscure GI bleeding or suspected small bowel lesions is shifting toward enteroscopic examination. Availability of an accessory channel now offers the clinician management options such as endoscopic injection therapy, electrocautery, and polypectomy. The "gold standard" for examination of the entire small bowel is intraoperative enteroscopy. A newer technique involving laparascopic assistance may lower the morbidity associated with this examination. Combined hormonal therapy may be an alternative treatment for patients with AVMs or an unknown cause of bleeding after enteroscopic examination.
小肠是胃肠道失血的一个罕见但重要的来源。在所有胃肠道出血的患者中,约5%即使经过广泛检查仍无明显出血原因。这种出血通常被称为“不明原因的胃肠道出血”或“隐匿性胃肠道出血”(OGIB)。小肠镜检查的最新进展有助于更好地了解小肠作为出血来源的情况。平均而言,27%的OGIB患者被发现小肠有病变,常见发现包括动静脉畸形(AVM)和小肠肿瘤。隐匿性胃肠道出血或疑似小肠病变的初步诊断检查趋势正转向小肠镜检查。现在有一个辅助通道可供临床医生选择管理方法,如内镜注射治疗、电灼和息肉切除术。检查整个小肠的“金标准”是术中小肠镜检查。一种涉及腹腔镜辅助的新技术可能会降低与此检查相关的发病率。联合激素治疗可能是小肠镜检查后患有AVM或不明出血原因患者的一种替代治疗方法。